Amino Acid Metabolism Disorder Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Arginine, Folic Acid, Thiamine, Carglumic Acid, Others); Application (Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia, Homocystinuria, Others); End User (Hospitals, Clinics, Others) and Geography
Report Code: TIPRE00018816 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Amino acids are also known as the building blocks that consolidate to frame proteins. There might be issues getting the amino acids into the cells. These issues cause the development of destructive substances in the body. This can prompt genuine, now and again dangerous, medical problems. This clutter is generally acquired. An infant who is conceived with one might not have any indications immediately post birth, however, might appear with time. As the disorders can be so genuine, early analysis and treatment are fundamental. Medications may consist of amino acid drugs, and supplements. A few infants may likewise require extra medicines if there are complexities.
MARKET DYNAMICS
The amino acid metabolism disorder drug market has shown a significant evolution over the forecast period. The rise of the amino acid metabolism disorder drug market is majorly driven by the rising prevalence of diseases caused due to imbalance of amino acids in the body. Moreover, the increasing demand for amino acids from the food, pharmaceutical, and nutraceutical industries fuels market growth. The amino acid drugs are widely being used in dietary supplements owing to their ability to treat muscle soreness and sprain, and mental fatigue. Moreover, a high rise in genetic amino acid disorders affecting infants is boosting the amino acid metabolism disorder drug market growth. Also, a rise in plant-based amino acid drugs is beneficial to the market. However, the production of plant-based amino acids is limited owing to the lack of production technology and the requirement of high capital cost.
MARKET SCOPE
The "Amino Acid Metabolism Disorder Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the amino acid metabolism disorder drug market with detailed market segmentation by product, application, and end-user. The amino acid metabolism disorder drug market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the amino acid metabolism disorder drug market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as arginine, folic acid, thiamine, carglumic acid, and others. Based on the application, the segmentation of the market is into phenylketonuria, maple syrup urine disease, argininosuccinic academia, homocystinuria, and others. Based on end user, the segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the amino acid metabolism disorder drug market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The amino acid metabolism disorder drug market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the amino acid metabolism disorder drug market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Amino acid metabolism disorder drug market in these regions.
The report contains critical developments in the amino acid metabolism disorder drug market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the amino acid metabolism disorder drug market are estimated to have profitable growth opportunities in the coming years with the higher demand for amino acid metabolism disorder drug in the global market. Given below is the list of a few companies engaged in the amino acid metabolism disorder drug market.
The report also offers key players' profiles in the amino acid metabolism disorder drug market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Eli Lilly and Company.
- Pfizer, Inc.
- sanofi-aventis U.S. LLC
- Johnson & Johnson Services, Inc.
- Bristol-Myers Squibb Company
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A
- Ajinomoto Co., Inc.
- AMINO GmbH
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
Amino acids are also known as the building blocks that consolidate to frame proteins. There might be issues getting the amino acids into the cells. These issues cause the development of destructive substances in the body. This can prompt genuine, now and again dangerous, medical problems. This clutter is generally acquired. An infant who is conceived with one might not have any indications immediately post birth, however, might appear with time. As the disorders can be so genuine, early analysis and treatment are fundamental. Medications may consist of amino acid drugs, and supplements. A few infants may likewise require extra medicines if there are complexities.
MARKET DYNAMICS
The amino acid metabolism disorder drug market has shown a significant evolution over the forecast period. The rise of the amino acid metabolism disorder drug market is majorly driven by the rising prevalence of diseases caused due to imbalance of amino acids in the body. Moreover, the increasing demand for amino acids from the food, pharmaceutical, and nutraceutical industries fuels market growth. The amino acid drugs are widely being used in dietary supplements owing to their ability to treat muscle soreness and sprain, and mental fatigue. Moreover, a high rise in genetic amino acid disorders affecting infants is boosting the amino acid metabolism disorder drug market growth. Also, a rise in plant-based amino acid drugs is beneficial to the market. However, the production of plant-based amino acids is limited owing to the lack of production technology and the requirement of high capital cost.
MARKET SCOPE
The "Amino Acid Metabolism Disorder Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the amino acid metabolism disorder drug market with detailed market segmentation by product, application, and end-user. The amino acid metabolism disorder drug market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on the leading players' market status in the amino acid metabolism disorder drug market and provides key opportunities and trends in the market.
MARKET SEGMENTATION
The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as arginine, folic acid, thiamine, carglumic acid, and others. Based on the application, the segmentation of the market is into phenylketonuria, maple syrup urine disease, argininosuccinic academia, homocystinuria, and others. Based on end user, the segmentation of the market is into hospitals, clinics, and others.
REGIONAL FRAMEWORK
The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the amino acid metabolism disorder drug market based on various segments. The report also consists of market size and forecast estimates from the year 2020 to2028with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The amino acid metabolism disorder drug market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the amino acid metabolism disorder drug market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the Amino acid metabolism disorder drug market in these regions.
The report contains critical developments in the amino acid metabolism disorder drug market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the amino acid metabolism disorder drug market are estimated to have profitable growth opportunities in the coming years with the higher demand for amino acid metabolism disorder drug in the global market. Given below is the list of a few companies engaged in the amino acid metabolism disorder drug market.
The report also offers key players' profiles in the amino acid metabolism disorder drug market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Eli Lilly and Company.
- Pfizer, Inc.
- sanofi-aventis U.S. LLC
- Johnson & Johnson Services, Inc.
- Bristol-Myers Squibb Company
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A
- Ajinomoto Co., Inc.
- AMINO GmbH
The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Amino Acid Metabolism Disorder Drug Market - By Product
1.3.2 Amino Acid Metabolism Disorder Drug Market - By Application
1.3.3 Amino Acid Metabolism Disorder Drug Market - By End User
1.3.4 Amino Acid Metabolism Disorder Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AMINO ACID METABOLISM DISORDER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AMINO ACID METABOLISM DISORDER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AMINO ACID METABOLISM DISORDER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. AMINO ACID METABOLISM DISORDER DRUG - GLOBAL MARKET OVERVIEW
6.2. AMINO ACID METABOLISM DISORDER DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ARGININE
7.3.1. Overview
7.3.2. Arginine Market Forecast and Analysis
7.4. FOLIC ACID
7.4.1. Overview
7.4.2. Folic Acid Market Forecast and Analysis
7.5. THIAMINE
7.5.1. Overview
7.5.2. Thiamine Market Forecast and Analysis
7.6. CARGLUMIC ACID
7.6.1. Overview
7.6.2. Carglumic Acid Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHENYLKETONURIA
8.3.1. Overview
8.3.2. Phenylketonuria Market Forecast and Analysis
8.4. MAPLE SYRUP URINE DISEASE
8.4.1. Overview
8.4.2. Maple Syrup Urine Disease Market Forecast and Analysis
8.5. ARGININOSUCCINIC ACIDEMIA
8.5.1. Overview
8.5.2. Argininosuccinic Acidemia Market Forecast and Analysis
8.6. HOMOCYSTINURIA
8.6.1. Overview
8.6.2. Homocystinuria Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. AMINO ACID METABOLISM DISORDER DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Amino Acid Metabolism Disorder Drug Market Overview
10.1.2 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.1.3 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.1.4 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.1.5 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.1.6 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Amino Acid Metabolism Disorder Drug Market
10.1.6.1.1 United States Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.1.2 United States Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.1.3 United States Amino Acid Metabolism Disorder Drug Market by End User
10.1.6.2 Canada Amino Acid Metabolism Disorder Drug Market
10.1.6.2.1 Canada Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.2.2 Canada Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.2.3 Canada Amino Acid Metabolism Disorder Drug Market by End User
10.1.6.3 Mexico Amino Acid Metabolism Disorder Drug Market
10.1.6.3.1 Mexico Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.3.2 Mexico Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.3.3 Mexico Amino Acid Metabolism Disorder Drug Market by End User
10.2. EUROPE
10.2.1 Europe Amino Acid Metabolism Disorder Drug Market Overview
10.2.2 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.2.3 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.2.4 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.2.5 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.2.6 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Amino Acid Metabolism Disorder Drug Market
10.2.6.1.1 Germany Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.1.2 Germany Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.1.3 Germany Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.2 France Amino Acid Metabolism Disorder Drug Market
10.2.6.2.1 France Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.2.2 France Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.2.3 France Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.3 Italy Amino Acid Metabolism Disorder Drug Market
10.2.6.3.1 Italy Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.3.2 Italy Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.3.3 Italy Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.4 Spain Amino Acid Metabolism Disorder Drug Market
10.2.6.4.1 Spain Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.4.2 Spain Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.4.3 Spain Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.5 United Kingdom Amino Acid Metabolism Disorder Drug Market
10.2.6.5.1 United Kingdom Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.5.2 United Kingdom Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.5.3 United Kingdom Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.6 Rest of Europe Amino Acid Metabolism Disorder Drug Market
10.2.6.6.1 Rest of Europe Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.6.2 Rest of Europe Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.6.3 Rest of Europe Amino Acid Metabolism Disorder Drug Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Overview
10.3.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Amino Acid Metabolism Disorder Drug Market
10.3.6.1.1 Australia Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.1.2 Australia Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.1.3 Australia Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.2 China Amino Acid Metabolism Disorder Drug Market
10.3.6.2.1 China Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.2.2 China Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.2.3 China Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.3 India Amino Acid Metabolism Disorder Drug Market
10.3.6.3.1 India Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.3.2 India Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.3.3 India Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.4 Japan Amino Acid Metabolism Disorder Drug Market
10.3.6.4.1 Japan Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.4.2 Japan Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.4.3 Japan Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.5 South Korea Amino Acid Metabolism Disorder Drug Market
10.3.6.5.1 South Korea Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.5.2 South Korea Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.5.3 South Korea Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.6 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market
10.3.6.6.1 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.6.2 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.6.3 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Overview
10.4.2 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Amino Acid Metabolism Disorder Drug Market
10.4.6.1.1 South Africa Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.1.2 South Africa Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.1.3 South Africa Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.2 Saudi Arabia Amino Acid Metabolism Disorder Drug Market
10.4.6.2.1 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.2.2 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.2.3 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.3 U.A.E Amino Acid Metabolism Disorder Drug Market
10.4.6.3.1 U.A.E Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.3.2 U.A.E Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.3.3 U.A.E Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.4 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market
10.4.6.4.1 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.4.2 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.4.3 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Amino Acid Metabolism Disorder Drug Market Overview
10.5.2 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.5.3 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.5.4 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.5.5 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.5.6 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Amino Acid Metabolism Disorder Drug Market
10.5.6.1.1 Brazil Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.1.2 Brazil Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.1.3 Brazil Amino Acid Metabolism Disorder Drug Market by End User
10.5.6.2 Argentina Amino Acid Metabolism Disorder Drug Market
10.5.6.2.1 Argentina Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.2.2 Argentina Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.2.3 Argentina Amino Acid Metabolism Disorder Drug Market by End User
10.5.6.3 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market
10.5.6.3.1 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.3.2 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.3.3 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AMINO ACID METABOLISM DISORDER DRUG MARKET, KEY COMPANY PROFILES
12.1. MERCK & CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI-AVENTIS U.S. LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON & JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL-MYERS SQUIBB COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AJINOMOTO CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMINO GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Amino Acid Metabolism Disorder Drug Market - By Product
1.3.2 Amino Acid Metabolism Disorder Drug Market - By Application
1.3.3 Amino Acid Metabolism Disorder Drug Market - By End User
1.3.4 Amino Acid Metabolism Disorder Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AMINO ACID METABOLISM DISORDER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AMINO ACID METABOLISM DISORDER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AMINO ACID METABOLISM DISORDER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. AMINO ACID METABOLISM DISORDER DRUG - GLOBAL MARKET OVERVIEW
6.2. AMINO ACID METABOLISM DISORDER DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ARGININE
7.3.1. Overview
7.3.2. Arginine Market Forecast and Analysis
7.4. FOLIC ACID
7.4.1. Overview
7.4.2. Folic Acid Market Forecast and Analysis
7.5. THIAMINE
7.5.1. Overview
7.5.2. Thiamine Market Forecast and Analysis
7.6. CARGLUMIC ACID
7.6.1. Overview
7.6.2. Carglumic Acid Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHENYLKETONURIA
8.3.1. Overview
8.3.2. Phenylketonuria Market Forecast and Analysis
8.4. MAPLE SYRUP URINE DISEASE
8.4.1. Overview
8.4.2. Maple Syrup Urine Disease Market Forecast and Analysis
8.5. ARGININOSUCCINIC ACIDEMIA
8.5.1. Overview
8.5.2. Argininosuccinic Acidemia Market Forecast and Analysis
8.6. HOMOCYSTINURIA
8.6.1. Overview
8.6.2. Homocystinuria Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. AMINO ACID METABOLISM DISORDER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. AMINO ACID METABOLISM DISORDER DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Amino Acid Metabolism Disorder Drug Market Overview
10.1.2 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.1.3 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.1.4 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.1.5 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.1.6 North America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Amino Acid Metabolism Disorder Drug Market
10.1.6.1.1 United States Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.1.2 United States Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.1.3 United States Amino Acid Metabolism Disorder Drug Market by End User
10.1.6.2 Canada Amino Acid Metabolism Disorder Drug Market
10.1.6.2.1 Canada Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.2.2 Canada Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.2.3 Canada Amino Acid Metabolism Disorder Drug Market by End User
10.1.6.3 Mexico Amino Acid Metabolism Disorder Drug Market
10.1.6.3.1 Mexico Amino Acid Metabolism Disorder Drug Market by Product
10.1.6.3.2 Mexico Amino Acid Metabolism Disorder Drug Market by Application
10.1.6.3.3 Mexico Amino Acid Metabolism Disorder Drug Market by End User
10.2. EUROPE
10.2.1 Europe Amino Acid Metabolism Disorder Drug Market Overview
10.2.2 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.2.3 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.2.4 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.2.5 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.2.6 Europe Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Amino Acid Metabolism Disorder Drug Market
10.2.6.1.1 Germany Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.1.2 Germany Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.1.3 Germany Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.2 France Amino Acid Metabolism Disorder Drug Market
10.2.6.2.1 France Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.2.2 France Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.2.3 France Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.3 Italy Amino Acid Metabolism Disorder Drug Market
10.2.6.3.1 Italy Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.3.2 Italy Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.3.3 Italy Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.4 Spain Amino Acid Metabolism Disorder Drug Market
10.2.6.4.1 Spain Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.4.2 Spain Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.4.3 Spain Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.5 United Kingdom Amino Acid Metabolism Disorder Drug Market
10.2.6.5.1 United Kingdom Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.5.2 United Kingdom Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.5.3 United Kingdom Amino Acid Metabolism Disorder Drug Market by End User
10.2.6.6 Rest of Europe Amino Acid Metabolism Disorder Drug Market
10.2.6.6.1 Rest of Europe Amino Acid Metabolism Disorder Drug Market by Product
10.2.6.6.2 Rest of Europe Amino Acid Metabolism Disorder Drug Market by Application
10.2.6.6.3 Rest of Europe Amino Acid Metabolism Disorder Drug Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Overview
10.3.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Amino Acid Metabolism Disorder Drug Market
10.3.6.1.1 Australia Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.1.2 Australia Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.1.3 Australia Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.2 China Amino Acid Metabolism Disorder Drug Market
10.3.6.2.1 China Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.2.2 China Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.2.3 China Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.3 India Amino Acid Metabolism Disorder Drug Market
10.3.6.3.1 India Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.3.2 India Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.3.3 India Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.4 Japan Amino Acid Metabolism Disorder Drug Market
10.3.6.4.1 Japan Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.4.2 Japan Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.4.3 Japan Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.5 South Korea Amino Acid Metabolism Disorder Drug Market
10.3.6.5.1 South Korea Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.5.2 South Korea Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.5.3 South Korea Amino Acid Metabolism Disorder Drug Market by End User
10.3.6.6 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market
10.3.6.6.1 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by Product
10.3.6.6.2 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by Application
10.3.6.6.3 Rest of Asia-Pacific Amino Acid Metabolism Disorder Drug Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Overview
10.4.2 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Amino Acid Metabolism Disorder Drug Market
10.4.6.1.1 South Africa Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.1.2 South Africa Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.1.3 South Africa Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.2 Saudi Arabia Amino Acid Metabolism Disorder Drug Market
10.4.6.2.1 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.2.2 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.2.3 Saudi Arabia Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.3 U.A.E Amino Acid Metabolism Disorder Drug Market
10.4.6.3.1 U.A.E Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.3.2 U.A.E Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.3.3 U.A.E Amino Acid Metabolism Disorder Drug Market by End User
10.4.6.4 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market
10.4.6.4.1 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by Product
10.4.6.4.2 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by Application
10.4.6.4.3 Rest of Middle East and Africa Amino Acid Metabolism Disorder Drug Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Amino Acid Metabolism Disorder Drug Market Overview
10.5.2 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis
10.5.3 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Product
10.5.4 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Application
10.5.5 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By End User
10.5.6 South and Central America Amino Acid Metabolism Disorder Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Amino Acid Metabolism Disorder Drug Market
10.5.6.1.1 Brazil Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.1.2 Brazil Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.1.3 Brazil Amino Acid Metabolism Disorder Drug Market by End User
10.5.6.2 Argentina Amino Acid Metabolism Disorder Drug Market
10.5.6.2.1 Argentina Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.2.2 Argentina Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.2.3 Argentina Amino Acid Metabolism Disorder Drug Market by End User
10.5.6.3 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market
10.5.6.3.1 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by Product
10.5.6.3.2 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by Application
10.5.6.3.3 Rest of South and Central America Amino Acid Metabolism Disorder Drug Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AMINO ACID METABOLISM DISORDER DRUG MARKET, KEY COMPANY PROFILES
12.1. MERCK & CO., INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI-AVENTIS U.S. LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON & JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL-MYERS SQUIBB COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AJINOMOTO CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMINO GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Merck & Co., Inc.
2. GlaxoSmithKline plc.
3. Eli Lilly and Company.
4. Pfizer, Inc.
5. sanofi-aventis U.S. LLC
6. Johnson & Johnson Services, Inc.
7. Bristol-Myers Squibb Company
8. RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A
9. Ajinomoto Co., Inc.
10. AMINO GmbH
1. Merck & Co., Inc.
2. GlaxoSmithKline plc.
3. Eli Lilly and Company.
4. Pfizer, Inc.
5. sanofi-aventis U.S. LLC
6. Johnson & Johnson Services, Inc.
7. Bristol-Myers Squibb Company
8. RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A
9. Ajinomoto Co., Inc.
10. AMINO GmbH
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
GET FREE SAMPLE PDF
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount